期刊
PHYSIOLOGICAL REPORTS
卷 10, 期 10, 页码 -出版社
WILEY
DOI: 10.14814/phy2.15298
关键词
heart rate variability; women; Estrogen; Menopause; menstrual cycle; female
类别
资金
- Canadian Institutes of Health Research
- Roy and Vi Baay Chair in Kidney Research
- William Davies Scholarship
Low estradiol status is associated with increased cardiovascular risk. Menopausal status and the high estradiol phase in premenopausal women are associated with reduced heart rate variability (HRV), a marker of cardiovascular risk. Understanding the role of estradiol in modulating cardiac autonomic tone may help guide risk reduction strategies in women.
Low estradiol status is associated with increased cardiovascular risk. We sought to determine the association between heart rate variability (HRV), a marker of cardiovascular risk, at baseline and in response to stressor as a function of menopausal status, menstrual cycle phase and estradiol level. Forty-one healthy women (13 postmenopausal, 28 premenopausal) were studied. Eleven premenopausal women were additionally studied in the high and low estradiol phases of the menstrual cycle. HRV was calculated by spectral power analysis (low Frequency (LF), high frequency (HF) and LF:HF) at baseline and in response to graded Angiotensin II (AngII) infusion. The primary outcomes were differences in HRV at baseline and in response to AngII. Compared to premenopausal women in the low estradiol phase, postmenopausal women demonstrated lower baseline LF (p = 0.01) and HF (p < 0.001) measures, which were not significant after adjustment for age and BMI. In response to AngII, a decrease in cardioprotective HRV (Delta HF = -0.43 +/- 0.46 ln ms(2), p = 0.005 vs. baseline) was observed in postmenopausal women versus premenopausal women. Baseline HRV parameters did not differ by menstrual phase in premenopausal women. During the low estradiol phase, no differences were observed in the HRV response to AngII challenge. In contrast, women in the high estradiol phase were unable to maintain HRV (Delta LF = -0.07 +/- 0.46 ln ms(2), p = 0.048 response vs. baseline, Delta HF = -0.33 +/- 0.74 ln ms2, p = 0.048 response vs. baseline). No association was observed between any measure of HRV and estradiol level. Menopausal status and the high estradiol phase in premenopausal women were associated with reduced HRV, a marker of cardiovascular risk. Understanding the role of estradiol in the modulation of cardiac autonomic tone may help guide risk reduction strategies in women.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据